ClinicalTrials.Veeva

Menu

Movement Analysis in Musculoskeletal Oncology: a Pilot Study (AnMov)

R

Regina Elena Cancer Institute

Status

Enrolling

Conditions

Motion Analysis in Musculoskeletal Oncology

Treatments

Device: Motion Analysis in Musculoskeletal Oncology

Study type

Observational

Funder types

Other

Identifiers

NCT05918549
RS1704/22

Details and patient eligibility

About

Noninterventional, prospective, multicenter pilot study of patients with primary and secondary musculoskeletal tumors designed to investigate functional outcomes after therapy using both subjective and quantitative motion detection techniques

Enrollment

30 estimated patients

Sex

All

Ages

6+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 6 years
  • Diagnosis of primary and secondary tumors of the musculoskeletal system
  • Patients who will need to undergo surgery for bone resection or wide excision of soft tissue lesion, and/or radiation or drug treatments
  • Availability of follow-up data (for at least 6 months)
  • Written informed consent

Exclusion criteria

  • Inability to perform pre-post treatment assessment

Trial design

30 participants in 1 patient group

Popolation
Treatment:
Device: Motion Analysis in Musculoskeletal Oncology

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems